Anti-inflammatory drugs use impacts the risk of developing PD in LRRK2 mutation carriers | 2020 | September - a podcast by International Parkinson and Movement Disorder Society

Dr. Marta San Luciano shares the main findings of the recently published article on the impact of non-steroidal anti-inflammatory drugs use on the risk of developing PD in a large LRRK2 mutation carriers cohort.

Further episodes of MDS Podcast

Further podcasts by International Parkinson and Movement Disorder Society

Website of International Parkinson and Movement Disorder Society